Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma

Condition:   Central Nervous System Lymphoma Intervention:   Drug: lenalidomide Sponsors:   Seoul National University Bundang Hospital;   Samyang BioPharm Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials